Diabetes remission and relapse after metabolic surgery.
Xiaoping ChenXiaomu KongPublished in: Journal of diabetes investigation (2018)
Metabolic surgery is an effective treatment option for obese patients with type 2 diabetes mellitus (T2DM). Frequent relapses and significantly decreased remission rates have been started after 10 and 15 years in surgically treated patients. Further concern should be warranted on predictors related to gastrointestinal hormones and metabolic profile of long-term remission and relapse of T2DM following metabolic surgery in obese patients.
Keyphrases
- obese patients
- bariatric surgery
- minimally invasive
- coronary artery bypass
- roux en y gastric bypass
- gastric bypass
- newly diagnosed
- disease activity
- type diabetes
- surgical site infection
- cardiovascular disease
- glycemic control
- ejection fraction
- ulcerative colitis
- weight loss
- prognostic factors
- rheumatoid arthritis
- free survival
- metabolic syndrome
- skeletal muscle
- coronary artery disease
- atrial fibrillation